News | Colonoscopy Systems | May 26, 2016

Check-Cap Announces Preliminary Data on Preparation-Free Colon Screening Capsule

Technology uses radio frequency telemetry to track capsule position through patient’s alimentary tract

Check-Cap capsule system, colon screening, colorectal cancer

May 26, 2016 — Check-Cap Ltd. announced that preliminary data from pre-clinical and clinical studies of its ingestible capsule for preparation-free colorectal cancer screening were discussed during Digestive Disease Week (DDW) 2016, May 21-24 in San Diego.

The presentation included a preliminary analysis of the first participants evaluated in the company's ongoing multi-center clinical feasibility study, which aims to establish the safety, functionality and preliminary efficacy of the Check-Cap system.

"While the potential health benefits of routine colorectal cancer screening are well understood, many patients are unwilling to undergo standard optical colonoscopy due to a perception of inconvenient bowel preparation requirements, concerns over pain and risks associated with anesthesia. Additionally, more than 20 percent of patients undergoing colonoscopy have inadequate bowel preparation, increasing the likelihood of complications and missed adenomas," said Prof. Nadir Arber, M.D., director of the Integrated Cancer Prevention Center (ICPC) at Tel Aviv Sourasky Medical Center, president of the Israeli Association of Gastroenterology and a lead investigator in the company's ongoing multi-center study.

"Preliminary findings demonstrated the feasibility of an alternative screening method that can generate structural data of the colon, without burdensome cleansing or diet restrictions, as required in current screening methods. These data support the Check-Cap system as a potentially attractive option for individuals in the target patient population that are not adherent to current medical guidelines."

Data presented showed safe and complete passage for the 75 participants enrolled in a completed study to assess the natural motility of the capsule.  Preliminary analysis of the ongoing clinical feasibility study evaluated data from 54 participants who swallowed Check-Cap's scanning capsule, tracking the passage of the capsule through the alimentary tract using radio frequency telemetry and Check-Cap's proprietary capsule position tracking system.

Capsule passage was safe and well-tolerated, with an average transit time of 66 ±37 hours observed in 53 volunteers who completed the study (one asymptomatic volunteer withdrew prior to completion and the capsule was retrieved endoscopically from the colon), and the total radiation dose was found to be ultra-low (0.03±0.007 mSv, or the equivalent exposure of one dental or chest X-ray). Three-dimensional image reconstructions of the colonic wall and lumen detected and located small and large pedunculated and sessile polyps, as validated by subsequent colonoscopy.

For more information: www.check-cap.com

Related Content

aycan completed the install of a second aycan xray-print solution at Inspira Health in New Jersey
News | X-Ray | February 10, 2020
February 10, 2020 — aycan completed the install of a second...
Rayence C-Series wireless DR detector

Image courtesy of Rayence

News | Digital Radiography (DR) | January 27, 2020
January 27, 2020 — The expansion of med...
Medical imaging technology company Oxipit announced partnership with Swiss medical distribution company Healthcare Konnect to bring ChestEye AI imaging suite to healthcare institutions in Nigeria
News | Artificial Intelligence | January 22, 2020
January 22, 2020 — Medical imaging technology company Oxipit ann
This is a lung X-ray reviewed automatically by artificial intelligence (AI) to identify a collapsed lung (pneumothorax) in the color coded area. This AI app from Lunit is awaiting final FDA review and in planned to be integrated into several vendors' mobile digital radiography (DR) systems. Fujifilm showed this software integrated as a work-in-progress into its mobile X-ray system at RSNA 2019. GE Healthcare has its own version of this software for its mobile r=ray systems that gained FDA in 2019.   #RSNA #

This is a lung X-ray reviewed automatically by artificial intelligence (AI) to identify a collapsed lung (pneumothorax) in the color coded area. This AI app from Lunit is awaiting final FDA review and in planned to be integrated into several vendors' mobile digital radiography (DR) systems. Fujifilm showed this software integrated as a work-in-progress into its mobile X-ray system at RSNA 2019. GE Healthcare has its own version of this software for its mobile r=ray systems that gained FDA in 2019.

Feature | RSNA | January 20, 2020 | Dave Fornell, Editor
Here are images of some of the newest new medical imaging technologies displayed on the expo floor at the ...
Nanox secures $26M supported by strategic investment from Foxconn, unveiling the Startek-inspired AI Biobed for early detection
News | X-Ray | January 16, 2020
January 16, 2020 — Nanox, an innovative medical imaging techn
Carestream’s X-ray digital tomosynthesis functionality creates three-dimensional datasets from digital radiography (DR) that can be scrolled through similar to computed tomography (CT) imaging. It received 510(k) clearance from the U.S. Food and Drug Administration (FDA) in January 2020. Digital tomosynthesis uses a single sweep of X-ray exposures and streamlines operator workflow by separating the process of DT exposure acquisition from image volume formation.
News | Digital Radiography (DR) | January 15, 2020
January 15, 2020 — Carestream’s X-ray digital tomosynthesis (DT) functionality, which creates three-dimensional datas
Sponsored Content | Videos | Digital Radiography (DR) | January 06, 2020
An experienced technologist and two Agfa executives talk about what distinguishes the new Agfa 100s.
 Piedmont Rockdale Hospital
News | Mobile Devices | December 19, 2019
December 19, 2019 — Piedmont Rockdale Hospital (Conyers, Ga.), a healthcare provider with a Level III Neonatal Intens